The findings showed increased risk of osteoporosis (relative risk 1.29), gout (relative risk 1.12), and, most strikingly, osteomalacia, which is a softening of the bones, with a relative risk of 2.55 [4]
Both medications can help reduce hunger, improve feelings of fullness, and support long-term weight loss, but individual results, side effects, and treatment suitability can vary
Some patients benefit from slower dose escalation, dietary modifications to increase bile flow, or alternative GLP-1 compounds that may carry different risk profiles
This commitment to transparency is part of our mission to make peptide therapy accessible and affordable for everyone at Desert Mobile Medical.
Modulates nitric oxide (NO) pathways , improving circulation and reducing oxidative stress